Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 2, 2022, 1Life Healthcare, Inc., or One Medical, held its 2022 Annual Meeting of Stockholders, or the Meeting. Present at the Meeting in person or by proxy were holders of 139,945,773 shares of One Medical common stock, representing approximately 72.3% of the eligible votes as of the close of business on April 4, 2022, or the Record Date. One Medical's stockholders voted on four proposals at the Meeting, each of which is described in more detail in One Medical's definitive proxy statement for the Meeting, filed with the Securities and Exchange Commission on April 21, 2022.

The final results with respect to each such proposal are set forth below:

Proposal 1 - Election of Directors.

The stockholders of One Medical elected each of the persons named below as Class II directors to serve until the 2025 annual meeting of stockholders and until their successors are duly elected and qualified. The voting results for each director nominee are set forth below:



      Director Nominee            Votes For       Votes Withheld        Broker Non-Votes
Paul R. Auvil                     74,417,005        23,779,759             41,749,009
Mark S. Blumenkranz, M.D.         74,411,434        23,785,330             41,749,009
Kalen F. Holmes, Ph.D.            72,663,697        25,533,067             41,749,009

Proposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm.

The stockholders ratified the appointment of PricewaterhouseCoopers LLP as One Medical's independent registered public accounting firm for the fiscal year ending December 31, 2022. The voting results are set forth below:



     For            Against        Abstain
 139,892,610        18,464         34,699

Proposal 3 - Non-binding Advisory Vote on Compensation of Named Executive Officers.

The stockholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers. The results of such vote were:



     For            Against         Abstain        Broker Non-Votes
  84,718,066       13,403,013       75,685            41,749,009

Proposal 4 - Non-binding Advisory Vote on Frequency of Future Non-binding Advisory Votes on Compensation of Named Executive Officers.

The stockholders indicated, on a non-binding advisory basis, their preference for one year as the frequency of holding future non-binding advisory votes on the compensation of the Company's named executive officers. The results of such vote were:



  One Year       Two Years      Three Years        Abstain        Broker Non-Votes
 97,974,429       17,775          114,539          90,021            41,749,009

Pursuant to the recommendation of the board of directors of the Company and consistent with the stockholders' preference, the Company plans to hold future non-binding advisory votes on the compensation of the Company's named executive officers every year. The next required non-binding advisory vote on the frequency of future non-binding advisory votes on the compensation of the Company's named executive officers will take place no later than at the Company's 2028 annual meeting of stockholders.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses